Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Bioenergetic Failure in Rat Oligodendrocyte Progenitor Cells Treated with Cerebrospinal Fluid Derived from Multiple Sclerosis Patients.

Mathur D, Riffo-Campos AL, Castillo J, Haines JD, Vidaurre OG, Zhang F, Coret-Ferrer F, Casaccia P, Casanova B, Lopez-Rodas G.

Front Cell Neurosci. 2017 Jul 18;11:209. doi: 10.3389/fncel.2017.00209. eCollection 2017.

2.

Effects of exogenous thymosin β4 on carbon tetrachloride-induced liver injury and fibrosis.

Li X, Wang L, Chen C.

Sci Rep. 2017 Jul 19;7(1):5872. doi: 10.1038/s41598-017-06318-5.

3.

TBK1: a new player in ALS linking autophagy and neuroinflammation.

Oakes JA, Davies MC, Collins MO.

Mol Brain. 2017 Feb 2;10(1):5. doi: 10.1186/s13041-017-0287-x. Review.

4.

Role of ROS and RNS Sources in Physiological and Pathological Conditions.

Di Meo S, Reed TT, Venditti P, Victor VM.

Oxid Med Cell Longev. 2016;2016:1245049. doi: 10.1155/2016/1245049. Epub 2016 Jul 12. Review.

5.

Redox Modulations, Antioxidants, and Neuropsychiatric Disorders.

Fraunberger EA, Scola G, Laliberté VL, Duong A, Andreazza AC.

Oxid Med Cell Longev. 2016;2016:4729192. doi: 10.1155/2016/4729192. Epub 2015 Nov 10. Review.

6.

Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.

Johnson DA, Johnson JA.

Free Radic Biol Med. 2015 Nov;88(Pt B):253-267. doi: 10.1016/j.freeradbiomed.2015.07.147. Epub 2015 Aug 14. Review.

8.

A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement.

Macchi Z, Wang Y, Moore D, Katz J, Saperstein D, Walk D, Simpson E, Genge A, Bertorini T, Fernandes JA, Swenson A, Elman L, Dimachkie M, Herbelin L, Miller J, Lu J, Wilkins H, Swerdlow RH, Statland J, Barohn R; Western ALS (WALS) Rasagiline Study Group.

Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(5-6):345-52. doi: 10.3109/21678421.2015.1026826. Epub 2015 Apr 2.

9.

A fruitful endeavor: modeling ALS in the fruit fly.

Casci I, Pandey UB.

Brain Res. 2015 May 14;1607:47-74. doi: 10.1016/j.brainres.2014.09.064. Epub 2014 Oct 5. Review.

10.

Mitochondrial metals as a potential therapeutic target in neurodegeneration.

Grubman A, White AR, Liddell JR.

Br J Pharmacol. 2014 Apr;171(8):2159-73. doi: 10.1111/bph.12513. Review.

11.

Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?

Muyderman H, Chen T.

Br J Pharmacol. 2014 Apr;171(8):2191-205. doi: 10.1111/bph.12476. Review.

12.

Effect of intra-cisternal application of kainic acid on the spinal cord and locomotor activity in rats.

Mitra NK, Goh TE, Bala Krishnan T, Nadarajah VD, Vasavaraj AK, Soga T.

Int J Clin Exp Pathol. 2013 Jul 15;6(8):1505-15. Print 2013.

13.

Is SOD1 loss of function involved in amyotrophic lateral sclerosis?

Saccon RA, Bunton-Stasyshyn RK, Fisher EM, Fratta P.

Brain. 2013 Aug;136(Pt 8):2342-58. doi: 10.1093/brain/awt097. Epub 2013 May 17. Review.

14.

Oxidative stress and superoxide dismutase in development, aging and gene regulation.

Allen RG.

Age (Omaha). 1998 Apr;21(2):47-76. doi: 10.1007/s11357-998-0007-7.

15.

Aging and oxygen toxicity: Relation to changes in melatonin.

Reiter RJ.

Age (Omaha). 1997 Oct;20(4):201-13. doi: 10.1007/s11357-997-0020-2.

16.

Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels.

Bartolome F, Wu HC, Burchell VS, Preza E, Wray S, Mahoney CJ, Fox NC, Calvo A, Canosa A, Moglia C, Mandrioli J, Chiò A, Orrell RW, Houlden H, Hardy J, Abramov AY, Plun-Favreau H.

Neuron. 2013 Apr 10;78(1):57-64. doi: 10.1016/j.neuron.2013.02.028. Epub 2013 Mar 14.

17.

Intakes of vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: pooled results from 5 cohort studies.

Fitzgerald KC, O'Reilly ÉJ, Fondell E, Falcone GJ, McCullough ML, Park Y, Kolonel LN, Ascherio A.

Ann Neurol. 2013 Feb;73(2):236-45. doi: 10.1002/ana.23820. Epub 2013 Jan 29.

18.

Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole.

Corcia P, Gordon PH.

Ther Clin Risk Manag. 2012;8:359-66. doi: 10.2147/TCRM.S21981. Epub 2012 Aug 27.

19.

Inhibition of TDP-43 accumulation by bis(thiosemicarbazonato)-copper complexes.

Parker SJ, Meyerowitz J, James JL, Liddell JR, Nonaka T, Hasegawa M, Kanninen KM, Lim S, Paterson BM, Donnelly PS, Crouch PJ, White AR.

PLoS One. 2012;7(8):e42277. doi: 10.1371/journal.pone.0042277. Epub 2012 Aug 3.

20.

The complex molecular biology of amyotrophic lateral sclerosis (ALS).

Redler RL, Dokholyan NV.

Prog Mol Biol Transl Sci. 2012;107:215-62. doi: 10.1016/B978-0-12-385883-2.00002-3. Review.

Supplemental Content

Support Center